Cancer drugs
Revolution Medicines gets FDA approval for targeted pancreatic cancer drug
Revolution said the drug is now available in the United States at $39,800 for a 30-day supply. The company added that it would make assistance available as well.
Israeli scientists launch worlds-first clinical trial for experimental pancreatic cancer treatment
Tel Aviv University study reveals how tumors hijack immune cells to fuel cancer growth and spread
Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim
New shot for cancer can eradicate whole tumors in patients, trial shows - report
Of the 102 participants, 43 saw a difference in the size of their tumors: some 28 saw their tumors shrink significantly, while 15 of the patients’ tumors dissolved altogether.
Late-stage trial finds a new pill extends survival for people with pancreatic cancer
The success of the Phase 3 study reverberated beyond the clinic, sending the company’s shares up more than a third in a single day.
The causes of rising colon cancer, the disease that caused James Van Der Beek's death - explainer
Dawson's Creek star James Van Der Beek's death at 48 underscores the growing trend of colon cancer among those under 50, now the leading cause of cancer death in this age group.
Iran executes at least 13 prisoners on Saturday morning as regime increases use of death penalty
The HRANA report comes as the Islamic Republic has been carrying out an increasing number of executions.
Oral cancer cases rise in Israel as HPV, smoking, alcohol consumption take effect
Oral cancer is considered one of the less-discussed malignancies, even though its incidence continues to rise steadily in Israel and worldwide.
Israel reviews cancer diagnoses after malfunction in Roche test kits for tumors
Urgent guidelines were issued to medical laboratories after a malfunction in Roche test kits was found. Laboratories are urged to destroy all stock of the faulty kits and conduct new tests.
Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
Israeli study uncovers cancer cell findings that may advance treatment for the disease
Researchers at Tel Aviv University found that aneuploid cancer cells are more sensitive to certain anti-cancer drugs, revealing potential targets for new treatments.
Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows
The findings are "preliminary evidence of the potential benefit" of GLP-1 drugs for cancer prevention in high-risk population.
Severe malfunction in cancer diagnosis device: Patients may have received incorrect treatment
Roche reported a malfunction in several devices for diagnosing cancerous tumors to the Health Ministry, which may have led to incorrect diagnoses and inappropriate treatment for cancer patients.
